Drug Recall Frequency
Recalls of compounded sterile products (CSPs) decreased again this year, driven by an ongoing decline in the number of CSP recalls from outsourced vendors. Most facilities have a recall system in place and these systems garner high marks from their users. More than 60% of facilities experiencing a recall over the past year were able to identify all of the patients who received the affected products.
More than 8 out of every 10 facilities has a system in place to identify recalled products used in compounding.
In-house recalls remain relatively rare; just 5% of facilities had to conduct a recall of an in-house compounded CSP over the past year. While recalls of outsourced products are somewhat more common, their frequency is on the decline. Just 13% of facilities recalled an outsourced CSP over the past year, down from a high of 41% 3 years ago.
Like what you've read? Please log in or create a free account to enjoy more of what www.pppmag.com has to offer.
Recent Popular Articles
Current Issue
